Mindpeak and Proscia Partner to Improve Cancer Diagnosis with Integrated AI-Powered Pathology Workflows
Summary
The newly announced partnership paves the way for delivering an integrated solution that brings together Mindpeak’s CE-IVD algorithms for immunohistochemistry (IHC) quantification* with Proscia’s CE-IVDR Concentriq® Dx** software platform. “Leading laboratories rely on Proscia’s Concentriq Dx because it offers the robust functionality needed to achieve fully digital diagnosis and is designed to seamlessly incorporate state-of-the-art AI into day-to-day operations. Our integrated solution will enable us to assist a larger number of pathologists and improve outcomes for even more patients.” Concentriq Dx is a modern digital pathology platform that drives primary diagnostic workflows for reference laboratories, hospitals, and health systems of all sizes. Its Concentriq digital pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate R&D, improve patient outcomes, and fulfill the promise of precision care. National Pathology Programme; doi: https://www.england.nhs.uk/wp-content/uploads/2014/02/pathol-dig-first.pdf [2] Colón, E. et al. (2023) AI in combination with the global counting methodology by the International Ki67 in Breast Cancer Working Group identifies more patients eligible for treatment and increases diagnostic speed by 5x-8x.
Classifications
AskAI Classifications
LabelsLinked Companies
